[CLINICAL TRIAL OF A NEW NEUROPLEGIC AGENT, DIXYRAZINE, WITH APPLICATION OF A DOUBLE-BLIND CONTROL METHOD AND SEQUENTIAL ANALYSIS].
D000293:Adolescent; D035843:Biomedical Research; D002648:Child; D002653:Child Behavior Disorders; D004311:Double-Blind Method; D006801:Humans; D006919:Hydroxyzine; D001523:Mental Disorders; D010640:Phenothiazines; D011395:Promazine; D014149:Tranquilizing Agents
D010640:Phenothiazines; D014149:Tranquilizing Agents; D006919:Hydroxyzine; C012950:dixyrazine; D011395:Promazine
ADOLESCENCE; CHILD; CHILD BEHAVIOR DISORDERS; CLINICAL RESEARCH; HYDROXYZINE; MENTAL DISORDERS; PROMAZINE; TRANQUILIZING AGENTS
ESSAI CLINIQUE D'UN NOUVEL AGENT NEUROPL'EGIQUE, LA DIXYRAZINE, AVEC APPLICATION D'UNE M'ETHODE DE CONTR OLE EN DOUBLE ANONYMAT ET DE L'ANALYSE S'EQUENTIELLE.